NuScale Power Stock Could Triple by 2030. Here's Why.

NuScale Power is pursuing a potential 6 GW SMR project for the Tennessee Valley Authority, with management targeting a power purchase agreement (PPA) by end-2026. The investment case hinges on replacing prior cost overruns (estimated costs rising from $4.2B in 2018 to $9.3B by 2023) that led to a prior cancellation, and a signed PPA could support >$1B revenue by 2030, but the deal is not yet binding. With NuScale shares down ~40% this year and the risk that delays could force shareholder dilution to stay solvent, the catalyst is meaningful but execution remains uncertain.

Analysis

The investable issue is not whether nuclear is “important,” but whether SMR can convert policy enthusiasm into a bankable contract without socializing cost overruns onto shareholders. A binding PPA would matter because it changes the equity from pure option value to something closer to financeable infrastructure, which is the difference between a narrative trade and a durable re-rating. The second-order winners are not just uranium names; they are fuel-cycle and critical-components providers that get pulled into any real buildout, while gas-peaker and other fast-cycle power alternatives risk losing some scarcity premium if utilities start locking in firm baseload earlier.

The main risk window is the next 3-6 months: the market will trade the probability of a signed, creditworthy agreement long before it prices actual construction. What can break the thesis is not just delay, but a term sheet that leaves too much construction, inflation, or financing risk with SMR; in that case, the headline catalyst may actually worsen dilution expectations. If rates stay elevated and TVA or other utilities insist on heavy contingencies, the “project won” narrative can still leave the equity unchanged or lower.

Consensus is probably overestimating how much a single PPA solves. The market may treat it as evidence of commercialization, but the harder part is converting approval into repeatable economics across a supply chain that still lacks volume history. The cleaner expression is to own the broader nuclear supply chain only after confirmation, while treating SMR itself as a high-beta financing event; if the stock spikes on rumor without binding terms, that is more likely an exit than an entry.

Key Decisions for Investors

• Do not chase SMR common ahead of a binding TVA PPA; if a signed contract is announced, consider a small starter long via 2027 call spreads to cap dilution and execution risk.
• Prefer a confirmation trade in URA or CCJ over SMR: long the nuclear fuel/supply-chain basket once a binding PPA is in hand, because the validation effect should be broader than the single-name equity.
• If SMR gaps up on non-binding headlines or deadline speculation, fade the move tactically with a short into strength; use the post-news high as the stop and reassess only if pricing and financing terms are disclosed.
• Set a hard watch item for Q4 2026: no signed PPA or evidence of another equity raise would falsify the commercialization thesis and likely reset the stock toward cash-burn optics.